Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus
- PMID: 21474997
- DOI: 10.4161/cc.10.8.15342
Polo-like kinase 1 regulates activation of AMP-activated protein kinase (AMPK) at the mitotic apparatus
Abstract
AMP-activated protein kinase (AMPK) is being primarily studied as a central metabolic stress sensor, which regulates cell survival and growth-related metabolic pathways to preserve intracellular ATP levels in response to energy deprivation. Evidence is now accumulating that AMPK plays also an obligatory role to ensure proper cell division and faithful chromosomal segregation during mitosis. Increased phosphorylation in the AMPK catalytic subunit (AMPKα) was found in a proteomic study for kinases activated during G2/M and, more recently, activated AMPKα (PP-AMPKα(Thr172)) has been observed to transiently associate with several mitotic structures including centrosomes, spindle poles, the central spindle midzone and the midbody throughout all of the mitotic stages and cytokinesis. How AMPKα activation is controlled spatially and temporally during mitosis, however, remained undiscovered. Because Polo-like Kinases (PLKs) regulate many aspects of mitotic progression including centrosome maturation, bipolar spindle assembly, chromosome congression & segregation, and cytokinesis, we decided to combine an immunofluorescence microscopy analysis with a chemical biology approach employing a small-molecule PLK1 inhibitor to dissect a putative relationship between PLK1 and AMPKα during G2/M transition. PLK1 and PP-AMPKα(Thr172) were found to display a major spatio-temporal overlap early at centrosomes, from prophase until anaphase, and late at the midbody, during telophase and cytokinesis. Moreover, short-term treatment with the thiophene derivative GW843682X, a selective PLK inhibitor that has 400-fold greater potency for PLK1 than for PLK2 or PLK3, fully abolished mitotic activation of AMPKα. Upon long-term PLK1 inhibition, PP-AMPKα(Thr172) was barely detected surrounding the spindle poles of prometaphase-like arrested cells displaying the "polo" phenotype. Similarly, PP-AMPKα(Thr172) was largely inhibited in GW843682X-treated cells exhibiting cytokinesis failure and binucleate cell formation. Given that PLK1 is a well-recognized master regulatory kinase for the numerous protein substrates involved in mitosis, our current description of a causal link between PLK1 activity and mitotic phosphorylation of AMPKα may provide fundamental insights into how the energy sensor AMPK is directly coupled to mitotic cell division and cell cycle exist.
Similar articles
-
The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis.Cell Cycle. 2009 Aug;8(15):2385-98. doi: 10.4161/cc.8.15.9082. Epub 2009 Aug 21. Cell Cycle. 2009. PMID: 19556893
-
Polo-like kinase 1 directs the AMPK-mediated activation of myosin regulatory light chain at the cytokinetic cleavage furrow independently of energy balance.Cell Cycle. 2012 Jul 1;11(13):2422-6. doi: 10.4161/cc.20438. Epub 2012 Jul 1. Cell Cycle. 2012. PMID: 22672936
-
DNA-PKcs associates with PLK1 and is involved in proper chromosome segregation and cytokinesis.J Cell Biochem. 2014 Jun;115(6):1077-88. doi: 10.1002/jcb.24703. J Cell Biochem. 2014. PMID: 24166892
-
14-3-3zeta cooperates with phosphorylated Plk1 and is required for correct cytokinesis.Front Biosci (Schol Ed). 2012 Jan 1;4(2):639-50. doi: 10.2741/s290. Front Biosci (Schol Ed). 2012. PMID: 22202082 Review.
-
Playing polo during mitosis: PLK1 takes the lead.Oncogene. 2017 Aug 24;36(34):4819-4827. doi: 10.1038/onc.2017.113. Epub 2017 Apr 24. Oncogene. 2017. PMID: 28436952 Review.
Cited by
-
AMP-activated protein kinase has diet-dependent and -independent roles in Drosophila oogenesis.Dev Biol. 2016 Dec 1;420(1):90-99. doi: 10.1016/j.ydbio.2016.10.006. Epub 2016 Oct 10. Dev Biol. 2016. PMID: 27729213 Free PMC article.
-
AGO2 localizes to cytokinetic protrusions in a p38-dependent manner and is needed for accurate cell division.Commun Biol. 2021 Jun 11;4(1):726. doi: 10.1038/s42003-021-02130-0. Commun Biol. 2021. PMID: 34117353 Free PMC article.
-
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response.Oncotarget. 2012 Sep;3(9):954-87. doi: 10.18632/oncotarget.652. Oncotarget. 2012. PMID: 23006971 Free PMC article. Review.
-
APC/C(Cdh1) targets brain-specific kinase 2 (BRSK2) for degradation via the ubiquitin-proteasome pathway.PLoS One. 2012;7(9):e45932. doi: 10.1371/journal.pone.0045932. Epub 2012 Sep 21. PLoS One. 2012. PMID: 23029325 Free PMC article.
-
PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3.Cancer Gene Ther. 2020 Jun;27(6):412-423. doi: 10.1038/s41417-019-0094-x. Epub 2019 Jun 12. Cancer Gene Ther. 2020. PMID: 31186514
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous